AXGN Q4 2022 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$36M+14.7% YoY

Gross Profit

$30M83.0% margin

Operating Income

-$6M-15.5% margin

Net Income

-$5M-15.0% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$195M

Total Liabilities

$94M

Stockholders' Equity

$101M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$32M	+14.7%
Gross Profit	$30M	$26M	+15.0%
Operating Income	-$6M	-$5M	-4.8%
Net Income	-$5M	-$5M	-2.4%